 NEW YORK, Feb. 10, 2021 PRNewswire -- Scopus BioPharma Inc. Nasdaq: SCPS today announced the closing of the underwriters over-allotment option in full, bringing total follow-on public offering proceeds to 10.35 million. Scopus is a biopharmaceutical company developing... 